Table of contents:
II. NIH Funding and You: Early Career and Early Career Investigator Symposium at SFN.
III. ABCD Study News
The annual NIDA-NIAAA Mini-Convention provides a forum for presentations and discussions of current topics in neuroscience and addiction research. Additionally, the Mini-Convention showcases research by premier early stage and junior investigators and is highlighted by a keynote address from the Jacob P. Waletzky Memorial Award Recipient. This year’s scientific sessions are: 1) Sensing New Opportunities for Addiction Neuroscience; 2) Novel Technologies and Innovative Approaches for Translational Research Targeting Alcohol and Substance Use Disorders; and 3) Rewriting Genes by CRISPR for Substance Dependence and Psychiatric Disorder Research. For additional information, please contact Roger Sorensen, NIDA [ rsorense@mail.nih.gov ] or John Matochik, NIAAA [ jmatochi@mail.nih.gov ], or visit https://apps1.seiservices.com/nida-niaaa/frontiers2019/.
NIH Funding and You: Early Career and Early Career Investigator Symposium at SFN.
Date and Time: October 21, 2019 at 6:30-9:00 pm
Location: McCormick Place Convention Center, Room S104
Food: Please visit before attending: Marriott Marquis Chicago, Hyatt Regency McCormick Place, or Hiltons at McCormick Place
There will be presentations from Program and Review staff from the National Institute on Drug Abuse (NIDA, NIH) on fellowships (F30, F31, F32, F99/K00), institutional appointments (T32, R25, K12), transition awards (K99/R00), mentored career development awards (K01, K08, K23, K25), special opportunities for international students, postdoctoral opportunities in NIH laboratories, independent research grants (R01, DP2, R03, and R21), and insights from review. Presentations will be followed by the opportunity to meet with Dr. Apkar Vania Apkarian, T32 directors, and NIDA staff.
A special headliner this year will be Dr. Apkarian, Project Director of the Center for Chronic Pain and Drug Abuse (P50) who will speak on pain, addiction, and P50 workforce opportunities. In keeping with the need to educate attendees about institutional appointments, T32 Project Directors will meet with students during our discussion period.
ABCD Study News
The Adolescent Brain Cognitive Development (ABCD) Study, the largest long-term study of brain development and child health in the United States, is tracking the development of 11,878 youth starting at ages 9–10 at regular intervals for a decade. Participants will undergo multimodal structural and functional neuroimaging, assessments of neurocognition, physical, and mental health, substance use, and culture and environment, as well as biospecimen collection for hormonal, genetic, environmental exposure, and substance use confirmation (visit the ABCD Study website to view the study's assessment protocols).
Approximately 100 terabytes of data obtained from the full participant cohort are available to scientists worldwide to conduct research on the many disparate factors that affect brain, cognitive, social, and emotional growth and, in turn, overall health and well-being.
- Data Release 2.0, available now on the NIMH Data Archive, includes baseline data on the full participant cohort, ages 9-10 years. Last year’s release (Data Release 1.1) contained baseline data on nearly half of the cohort.
- This release includes much of the same type of data as contained in Data Release 1.1, but also includes genotypic data for the first time:
- Genomics data (Smokescreen genotyping array) are available on almost 11,000 participants. These include common variations, as well as variations associated with addiction, smoking behavior and nicotine metabolism.
- A Data Exploration and Analysis Portal (DEAP) is available on the NIMH Data Archive to facilitate analysis of ABCD Study data. The DEAP allows authorized users to analyze ABCD Study data online, while providing appropriate statistical models and tools that take advantage of the study design.
- Data will be released annually. The next data release will be in early summer 2020 and will include the first longitudinal data from the 6-month and 1-year follow-up assessments.
For more information about Data Release 2.0 and to request access to the data, visit the ABCD data collection on the NIMH Data Archive.
An educational course called “Researchers' Guide to the Adolescent Brain Cognitive Development (ABCD) Study” will be held at the 2019 Organization for Human Brain Mapping Annual Meeting in Rome on Sunday, June 09, 2019. This half-day course introduces the study, ways of accessing different raw and curated datasets, leveraging new analytical tools to accelerate research, and statistical considerations important in population studies. For further information see the Meetings & Events at www.humanbrainmapping.org.
---------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment